Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma

被引:56
作者
Csatary, LK [1 ]
Bakács, T
机构
[1] United Canc Inst, Alexandria, VA 22306 USA
[2] Natl Inst Oncol, Budapest, Hungary
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1999年 / 281卷 / 17期
关键词
D O I
10.1001/jama.281.17.1588-a
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1588 / 1589
页数:2
相关论文
共 7 条
[1]  
CASSEL WA, 1965, CANCER, V18, P863, DOI 10.1002/1097-0142(196507)18:7<863::AID-CNCR2820180714>3.0.CO
[2]  
2-V
[3]  
CSATARY LK, 1993, CANCER DETECT PREV, V17, P619
[4]  
CSATARY LK, 1971, LANCET, V2, P825
[5]  
Csatary LK, 1999, ANTICANCER RES, V19, P629
[6]   COMPLETE REGRESSION OF HUMAN NEUROBLASTOMA XENOGRAFTS IN ATHYMIC MICE AFTER LOCAL NEWCASTLE-DISEASE VIRUS THERAPY [J].
LORENCE, RM ;
REICHARD, KW ;
KATUBIG, BB ;
REYES, HM ;
PHUANGSAB, A ;
MITCHELL, BR ;
CASCINO, CJ ;
WALTER, RJ ;
PEEPLES, ME .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (16) :1228-1233
[7]  
WEBB HE, 1970, LANCET, V1, P1206